FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045557577> ?p ?o ?g. }

• W2045557577 abstract "The study was conducted to evaluate the possibility of selecting convalescent diphtheria patients to serve in emergency situations as donors for the production of anti-diphtheria immunoglobulin. To select suitable donors, the criterion of an antitoxin titer >/=3.0 IU/ml was used. In addition, the effects of treatment and the effect of immunization with diphtheria toxoid on the level of anti-diphtheria toxin antibodies were evaluated.Three groups of diphtheria patients were included in the study. The first group (n = 23) consisted of patients who had a basic antibiotic treatment, with or without serotherapy using horse antitoxin and/or human immunoglobulin. The second group (n = 12) comprised patients examined immediately after the onset of disease. The immunological history of this group was not known. The third group (n = 20) included patients with a known immunization history, treated only with antibiotics but having received a booster immunization with diphtheria toxoid. Antitoxin titers were measured using the toxin binding inhibition (ToBI) assay.In the first group, 47.8% (11/23) of the patients had a diphtheria antibody titer >/=3.0 IU/ml. For most of them, however, the antibody titers could have resulted from treatment with exogenous antibodies from horse antitoxin or human immunoglobulin (18/23). Only two of the 11 high-titer subjects had received antibiotics only. Among the second group, only two (16.76%) of the patients had an antibody titer of >/=3.0 IU/ml. In the third group 50% (10/20) of the patients showed an antibody titer of >/=3.0 IU/ml prior to vaccination, and therefore could be directly considered as donors. Three weeks after booster vaccination, 70% (14/20) had an antibody titer of >/=3.0 IU/ml and 1 year after booster vaccination, 28.6% (2/7) of the subjects still had titers of >/=3.0 IU/ml. In 40% of these patients, a decrease was observed 3-4 weeks after the booster dose. It was concluded that convalescent diphtheria patients could be considered as donors in an emergency situation, since approximately half of them showed antitoxin titers of >/=3.0 IU/ml." @default.
• W2045557577 created "2016-06-24" @default.
• W2045557577 creator A5001086053 @default.
• W2045557577 creator A5014407907 @default.
• W2045557577 creator A5016986757 @default.
• W2045557577 creator A5020796910 @default.
• W2045557577 creator A5026708360 @default.
• W2045557577 creator A5049512165 @default.
• W2045557577 creator A5069630359 @default.
• W2045557577 creator A5070488251 @default.
• W2045557577 creator A5083272061 @default.
• W2045557577 date "2004-05-01" @default.
• W2045557577 modified "2023-09-27" @default.
• W2045557577 title "Evaluation of diphtheria convalescent patients to serve as donors for the production of anti-diphtheria immunoglobulin preparations" @default.
• W2045557577 cites W1964377532 @default.
• W2045557577 cites W1975568142 @default.
• W2045557577 cites W1981104799 @default.
• W2045557577 cites W2001666810 @default.
• W2045557577 cites W2004999595 @default.
• W2045557577 cites W2006837003 @default.
• W2045557577 cites W2008514143 @default.
• W2045557577 cites W2010808153 @default.
• W2045557577 cites W2013290903 @default.
• W2045557577 cites W2020880570 @default.
• W2045557577 cites W2038342684 @default.
• W2045557577 cites W2041267993 @default.
• W2045557577 cites W2044197269 @default.
• W2045557577 cites W2050902734 @default.
• W2045557577 cites W2056259028 @default.
• W2045557577 cites W2057712912 @default.
• W2045557577 cites W2061315898 @default.
• W2045557577 cites W2066485051 @default.
• W2045557577 cites W2076718235 @default.
• W2045557577 cites W2076859946 @default.
• W2045557577 cites W2097938325 @default.
• W2045557577 cites W2104341428 @default.
• W2045557577 cites W2106412572 @default.
• W2045557577 cites W2121334786 @default.
• W2045557577 cites W2137156254 @default.
• W2045557577 cites W2144959592 @default.
• W2045557577 cites W2146188636 @default.
• W2045557577 cites W2146285334 @default.
• W2045557577 cites W2146831228 @default.
• W2045557577 cites W2157225625 @default.
• W2045557577 cites W2159523690 @default.
• W2045557577 cites W80663818 @default.
• W2045557577 doi "https://doi.org/10.1016/j.vaccine.2003.11.006" @default.
• W2045557577 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15121299" @default.
• W2045557577 hasPublicationYear "2004" @default.
• W2045557577 type Work @default.
• W2045557577 sameAs 2045557577 @default.
• W2045557577 citedByCount "5" @default.
• W2045557577 countsByYear W20455575772013 @default.
• W2045557577 countsByYear W20455575772014 @default.
• W2045557577 countsByYear W20455575772016 @default.
• W2045557577 countsByYear W20455575772021 @default.
• W2045557577 crossrefType "journal-article" @default.
• W2045557577 hasAuthorship W2045557577A5001086053 @default.
• W2045557577 hasAuthorship W2045557577A5014407907 @default.
• W2045557577 hasAuthorship W2045557577A5016986757 @default.
• W2045557577 hasAuthorship W2045557577A5020796910 @default.
• W2045557577 hasAuthorship W2045557577A5026708360 @default.
• W2045557577 hasAuthorship W2045557577A5049512165 @default.
• W2045557577 hasAuthorship W2045557577A5069630359 @default.
• W2045557577 hasAuthorship W2045557577A5070488251 @default.
• W2045557577 hasAuthorship W2045557577A5083272061 @default.
• W2045557577 hasConcept C159654299 @default.
• W2045557577 hasConcept C203014093 @default.
• W2045557577 hasConcept C22070199 @default.
• W2045557577 hasConcept C22889606 @default.
• W2045557577 hasConcept C2777351567 @default.
• W2045557577 hasConcept C2777367657 @default.
• W2045557577 hasConcept C2778973234 @default.
• W2045557577 hasConcept C2780572238 @default.
• W2045557577 hasConcept C2780801004 @default.
• W2045557577 hasConcept C2781288345 @default.
• W2045557577 hasConcept C32611913 @default.
• W2045557577 hasConcept C33057221 @default.
• W2045557577 hasConcept C501593827 @default.
• W2045557577 hasConcept C71924100 @default.
• W2045557577 hasConcept C86803240 @default.
• W2045557577 hasConcept C89423630 @default.
• W2045557577 hasConceptScore W2045557577C159654299 @default.
• W2045557577 hasConceptScore W2045557577C203014093 @default.
• W2045557577 hasConceptScore W2045557577C22070199 @default.
• W2045557577 hasConceptScore W2045557577C22889606 @default.
• W2045557577 hasConceptScore W2045557577C2777351567 @default.
• W2045557577 hasConceptScore W2045557577C2777367657 @default.
• W2045557577 hasConceptScore W2045557577C2778973234 @default.
• W2045557577 hasConceptScore W2045557577C2780572238 @default.
• W2045557577 hasConceptScore W2045557577C2780801004 @default.
• W2045557577 hasConceptScore W2045557577C2781288345 @default.
• W2045557577 hasConceptScore W2045557577C32611913 @default.
• W2045557577 hasConceptScore W2045557577C33057221 @default.
• W2045557577 hasConceptScore W2045557577C501593827 @default.
• W2045557577 hasConceptScore W2045557577C71924100 @default.
• W2045557577 hasConceptScore W2045557577C86803240 @default.
• W2045557577 hasConceptScore W2045557577C89423630 @default.
• W2045557577 hasLocation W20455575771 @default.
• W2045557577 hasLocation W20455575772 @default.

• next